MERIDIAN BIOSCIENCE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-12-13: Reporting owner LUEKE MELISSA; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-13: Reporting owner LUEKE MELISSA; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-11: Reporting owner EBERLY RICHARD; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-11: Reporting owner EBERLY RICHARD; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-12-13 | LUEKE MELISSA Officer (Exec VP, CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,250 0 owned after | $4.53 exercise price | 2012-12-17 | |
| 2012-12-13 | LUEKE MELISSA Officer (Exec VP, CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,750 0 owned after | $16.55 exercise price | 2012-12-17 | |
| 2012-12-11 | EBERLY RICHARD Officer (EVP,Pres Meridian Life Science) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,250 0 owned after | $7.28 exercise price | 2012-12-13 | |
| 2012-12-11 | EBERLY RICHARD Officer (EVP,Pres Meridian Life Science) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,500 0 owned after | $14.01 exercise price | 2012-12-13 | |
| 2012-12-11 | EBERLY RICHARD Officer (EVP,Pres Meridian Life Science) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,750 0 owned after | $16.55 exercise price | 2012-12-13 | |
| 2012-12-06 | READY ROBERT J Director | 4/A | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,214 0 owned after | $3.72 exercise price | 2013-12-06 | |
| 2012-12-05 | MOTTO WILLIAM J Director, Officer (Executive Chairman) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,750 0 owned after | $4.53 exercise price | 2012-12-07 | |
| 2012-11-13 | ROLIH SUSAN Officer (Sr. VP, Reg Affairs and QA) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −22,500 0 owned after | $2.80 exercise price | 2012-11-15 | |
| 2012-09-10 | MOTTO WILLIAM J Director, Officer (Executive Chairman) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,988 0 owned after | $2.80 exercise price | 2012-09-11 | |
| 2012-06-01 | Elagin Vecheslav A Officer (EVP, Research & Development) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $18.91 exercise price | 2012-11-09 | |
| 2012-01-25 | PHILLIPS DAVID Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $18.54 exercise price | 2012-01-27 | |
| 2012-01-25 | Anderson James M. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $18.54 exercise price | 2012-01-27 | |
| 2012-01-25 | READY ROBERT J Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $18.54 exercise price | 2012-01-27 | |
| 2012-01-11 | READY ROBERT J Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,214 0 owned after | $2.73 exercise price | 2012-01-27 |